UBS Group
BHVN icon

UBS Group’s Biohaven BHVN Stock Holding History

UBS Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-105,400
Closed -$1.19M – 10505
2025
Q4 		$1.19M Buy
105,400
+54,800
+108% +$679K ﹤0.01% 5427
2025
Q3 		$760K Buy
+50,600
New +$737K ﹤0.01% 5782
2025
Q2 		– Sell
-7,600
Closed -$183K – 10260
2025
Q1 		$183K Buy
+7,600
New +$268K ﹤0.01% 6614

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's BHVN Position: Q2 2026 in Review

UBS Group increased its Biohaven (BHVN) stake by 77% in Q2 2026, buying an estimated $11.8M and bringing the position to 2,518,827 shares worth $37.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2038.

UBS Group first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • UBS Group held 2,518,827 shares of Biohaven worth $37.5M as of Q2 2026.
  • UBS Group bought 1,092,400 Biohaven shares in Q2 2026, an estimated $11.8M.
  • Biohaven made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2038 holding.
  • UBS Group first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.